What Is Lung Cancer?
Lung cancer is a devastating disease for patients and their families, and is the leading cause of cancer death worldwide, more than breast and prostate cancer combined (1). The two main lung cancer types are non-small cell lung cancer (NSCLC 80-85%) and small cell lung cancer (SCLC 15%), a more aggressive cancer when compared to NSCLC (2, 3).
Lung cancer is complexified by various histopathologies (e.g., adenocarcinoma, squamous, large cell, and more) and numerous clinically meaningful biomarkers that need to be assessed to provide the best treatment or select the right trial for patients (e.g., EGFR, ALK, ROS1, and more) (4). Cerba Research offers a wide range of histopathology and clinically meaningful biomarker capabilities that can be detected with cutting-edge techniques. Contact us to find out more.

Lung Cancer Lesion